DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Sanofi India Limited — Change in Management

NSE 1 hr ago·31 Jul 2026, 9:21 am

Sanofi India

Sanofi India has announced a change in its senior management personnel, as required by SEBI regulations. This update signals a shift in the company's leadership structure.

For investors, such changes can be a double-edged sword. On one hand, fresh leadership often brings new strategies and perspectives that could drive growth. On the other hand, it may temporarily create uncertainty regarding the company's future direction and operational continuity.

Investors should monitor the new leadership's immediate actions and strategic plans. It is also important to assess whether this change aligns with the company's long-term goals and market performance.